We provide you with 20 years of free, institutional-grade data for VBLT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VBLT. Explore the full financial landscape of VBLT stock.
| Reported Date | CIK | Ticker | Type |
|---|
Vascular Biogenics Ltd(NASDAQ:VBLT) 
Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer and immune/inflammatory indications. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes ge...
Website: http://www.vblrx.com
Founded: 2000
Full Time Employees: 38
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VBLT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.